CIK: 0001595851 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value: $361M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SER TR | 250,000 | $23.72M | 6.6% | $94.89 | — | — | Put | 78464A870 |
| AXSM | AXSOME THERAPEUTICS INC | 210,000 | $16.76M | 4.6% | $79.80 * | $54.36 | +54.4% | COM | 05464T104 |
| SRPT | SAREPTA THERAPEUTICS INC | 125,000 | $16.18M | 4.5% | $129.46 * | $101.29 | +20.9% | COM | 803607100 |
| BHVN | BIOHAVEN LTD | 285,000 | $15.59M | 4.3% | $54.69 * | $31.75 | +56.0% | COM | G1110E107 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 300,000 | $15.07M | 4.2% | $50.23 * | $45.36 | +19.6% | CLASS A ORD | 61559X104 |
| ROIV | ROIVANT SCIENCES LTD | 1,300,000 | $13.7M | 3.8% | $10.54 * | $10.26 | +5.0% | SHS | G76279101 |
| TGTX | TG THERAPEUTICS INC | 825,000 | $12.55M | 3.5% | $15.21 * | $15.64 | +1.9% | COM | 88322Q108 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 625,000 | $10.94M | 3.0% | $17.51 * | $19.55 | -0.9% | COM | 92790C104 |
| TARS | TARSUS PHARMACEUTICALS INC | 300,000 | $10.9M | 3.0% | $36.35 * | $20.09 | +46.4% | COM | 87650L103 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 200,000 | $9.362M | 2.6% | $46.81 * | $33.11 | +18.2% | COM | 22663K107 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 60,000 | $8.967M | 2.5% | $149.45 * | $168.43 | -1.0% | COM | 02043Q107 |
| SLNO | SOLENO THERAPEUTICS INC | 200,000 | $8.56M | 2.4% | $42.80 * | $35.80 | +26.3% | COM | 834203309 |
| SVRA | SAVARA INC | 1,600,000 | $7.968M | 2.2% | $4.98 * | $4.36 | +10.7% | COM | 805111101 |
| APLS | APELLIS PHARMACEUTICALS INC | 130,000 | $7.641M | 2.1% | $58.78 * | $63.75 | 0.0% | COM | 03753U106 |
| — | PERSPECTIVE THERAPEUTICS INC | 6,000,000 | $7.14M | 2.0% | $1.19 | $0.98 | — | COM | 46489V104 |
| — | BLUEPRINT MEDICINES CORP | 72,761 | $6.902M | 1.9% | $94.86 | $94.86 | — | COM | 09627Y109 |
| — | AEROVATE THERAPEUTICS INC | 225,000 | $6.653M | 1.8% | $29.57 | $18.73 | — | COM | 008064107 |
| VKTX | VIKING THERAPEUTICS INC | 80,000 | $6.56M | 1.8% | $82.00 * | $44.50 | 0.0% | Call | 92686J106 |
| PCVX | VAXCYTE INC | 95,000 | $6.489M | 1.8% | $68.31 | $41.68 | +66.2% | COM | 92243G108 |
| CABA | CABALETTA BIO INC | 375,000 | $6.397M | 1.8% | $17.06 * | $19.60 | +9.5% | COM | 12674W109 |
| VKTX | VIKING THERAPEUTICS INC | 73,002 | $5.986M | 1.7% | $82.00 * | $44.50 | 0.0% | COM | 92686J106 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 125,000 | $5.416M | 1.5% | $43.33 | $43.76 | 0.0% | COM | 76243J105 |
| BBIO | BRIDGEBIO PHARMA INC | 175,000 | $5.411M | 1.5% | $30.92 * | $26.78 | +27.0% | COM | 10806X102 |
| REPL | REPLIMUNE GROUP INC | 650,000 | $5.311M | 1.5% | $8.17 | $10.29 | -20.3% | COM | 76029N106 |
| CYTK | CYTOKINETICS INC | 75,000 | $5.258M | 1.5% | $70.11 * | $55.32 | +39.8% | Call | 23282W605 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 485,000 | $5.151M | 1.4% | $10.62 * | $11.96 | -29.0% | COM | 71722W107 |
| IMVT | IMMUNOVANT INC | 150,000 | $4.846M | 1.3% | $32.31 * | $36.48 | 0.0% | Call | 45258J102 |
| ACAD | ACADIA PHARMACEUTICALS INC | 225,000 | $4.16M | 1.2% | $18.49 * | $25.31 | -2.1% | COM | 004225108 |
| INSM | INSMED INC | 150,000 | $4.069M | 1.1% | $27.13 * | $27.99 | 0.0% | COM PAR $.01 | 457669307 |
| TNYA | TENAYA THERAPEUTICS INC | 775,000 | $4.053M | 1.1% | $5.23 * | $4.78 | 0.0% | COM | 87990A106 |
| IMVT | IMMUNOVANT INC | 125,000 | $4.039M | 1.1% | $32.31 * | $36.48 | 0.0% | COM | 45258J102 |
| SYRE | SPYRE THERAPEUTICS INC | 100,000 | $3.793M | 1.0% | $37.93 * | $28.97 | 0.0% | COM NEW | 00773J202 |
| ACAD | ACADIA PHARMACEUTICALS INC | 200,000 | $3.698M | 1.0% | $18.49 * | $25.31 | -2.1% | Call | 004225108 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 150,000 | $3.57M | 1.0% | $23.80 * | $22.30 | 0.0% | COM | 87164F105 |
| — | INTRA-CELLULAR THERAPIES INC | 50,000 | $3.46M | 1.0% | $69.20 | — | — | Call | 46116X101 |
| ENGN | ENGENE HOLDINGS INC | 200,000 | $3.39M | 0.9% | $16.95 * | $12.24 | 0.0% | COM | 29286M105 |
| CGON | CG ONCOLOGY INC | 75,000 | $3.292M | 0.9% | $43.90 * | $40.84 | 0.0% | COM | 156944100 |
| GPCR | STRUCTURE THERAPEUTICS INC | 75,000 | $3.215M | 0.9% | $42.86 | $44.30 | — | SPONSORED ADS | 86366E106 |
| BBOT | HELIX ACQUISITION CORP II | 300,000 | $3.12M | 0.9% | $10.40 | $10.35 | 0.0% | CL A ORD SHS | G4444H101 |
| COGT | COGENT BIOSCIENCES INC | 450,000 | $3.024M | 0.8% | $6.72 * | $8.27 | -25.2% | COM | 19240Q201 |
| AQST | AQUESTIVE THERAPEUTICS INC | 702,941 | $2.995M | 0.8% | $4.26 * | $3.33 | 0.0% | COM | 03843E104 |
| — | DECIPHERA PHARMACEUTICALS IN | 176,513 | $2.777M | 0.8% | $15.73 | $12.72 | — | COM | 24344T101 |
| TSHA | TAYSHA GENE THERAPIES INC | 950,000 | $2.727M | 0.8% | $2.87 * | $1.91 | +8.9% | COM SHS | 877619106 |
| — | RAPT THERAPEUTICS INC | 300,000 | $2.694M | 0.7% | $8.98 | — | — | Call | 75382E109 |
| GERN | GERON CORP | 800,000 | $2.64M | 0.7% | $3.30 * | $2.23 | 0.0% | COM | 374163103 |
| — | MARINUS PHARMACEUTICALS INC | 285,000 | $2.576M | 0.7% | $9.04 | $9.91 | — | COM NEW | 56854Q200 |
| ALT | ALTIMMUNE INC | 250,000 | $2.545M | 0.7% | $10.18 | $10.17 | 0.0% | COM NEW | 02155H200 |
| RGNX | REGENXBIO INC | 120,000 | $2.528M | 0.7% | $21.07 * | $17.79 | 0.0% | COM | 75901B107 |
| KRYS | KRYSTAL BIOTECH INC | 14,000 | $2.491M | 0.7% | $177.93 * | $117.03 | +18.7% | COM | 501147102 |
| KALV | KALVISTA PHARMACEUTICALS INC | 200,000 | $2.372M | 0.7% | $11.86 * | $11.14 | +19.7% | COM | 483497103 |
| NTRA | NATERA INC | 25,000 | $2.287M | 0.6% | $91.46 * | $49.96 | +50.6% | COM | 632307104 |
| OLMA | OLEMA PHARMACEUTICALS INC | 200,000 | $2.264M | 0.6% | $11.32 * | $12.90 | 0.0% | COM | 68062P106 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 56,941 | $2.234M | 0.6% | $39.24 * | $24.66 | 0.0% | COM NEW | 21833P301 |
| — | REVANCE THERAPEUTICS INC | 450,000 | $2.214M | 0.6% | $4.92 | $21.62 | — | COM | 761330109 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 75,000 | $2.17M | 0.6% | $28.93 * | $17.94 | +51.7% | COM | 74366E102 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 90,000 | $1.86M | 0.5% | $20.67 * | $10.97 | +125.8% | COM NEW | 30233G209 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 6,500 | $1.736M | 0.5% | $267.04 * | $197.50 | +19.3% | COM | 558868105 |
| ARVN | ARVINAS INC | 40,000 | $1.651M | 0.5% | $41.28 * | $23.38 | +86.9% | COM | 04335A105 |
| — | ASTRIA THERAPEUTICS INC | 115,000 | $1.619M | 0.4% | $14.07 | $8.90 | — | COM | 04635X102 |
| LRMR | LARIMAR THERAPEUTICS INC | 210,603 | $1.598M | 0.4% | $7.59 * | $7.79 | 0.0% | COM | 517125100 |
| CYTK | CYTOKINETICS INC | 20,000 | $1.402M | 0.4% | $70.11 * | $55.32 | +39.8% | COM NEW | 23282W605 |
| CTMX | CYTOMX THERAPEUTICS INC | 600,000 | $1.308M | 0.4% | $2.18 * | $1.85 | 0.0% | COM | 23284F105 |
| — | ELEVATION ONCOLOGY INC | 250,000 | $1.282M | 0.4% | $5.13 | $5.13 | — | COM | 28623U101 |
| NGNE | NEUROGENE INC | 25,000 | $1.272M | 0.4% | $50.90 * | $33.40 | 0.0% | COM | 64135M105 |
| SGMT | SAGIMET BIOSCIENCES INC | 225,000 | $1.22M | 0.3% | $5.42 * | $7.18 | 0.0% | COM SER A | 786700104 |
| ATYR | ATYR PHARMA INC | 600,000 | $1.17M | 0.3% | $1.95 * | $1.74 | 0.0% | COM NEW | 002120202 |
| PMVP | PMV PHARMACEUTICALS INC | 675,000 | $1.147M | 0.3% | $1.70 * | $6.13 | -69.5% | COM | 69353Y103 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 35,000 | $1.001M | 0.3% | $28.60 * | $31.99 | 0.0% | COM | 04280A100 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 20,000 | $934K | 0.3% | $46.69 | $47.17 | 0.0% | COM | 90400D108 |
| QURE | UNIQURE NV | 165,000 | $858K | 0.2% | $5.20 * | $20.98 | -72.7% | SHS | N90064101 |
| ANTX | AN2 THERAPEUTICS INC | 219,331 | $713K | 0.2% | $3.25 * | $10.88 | 0.0% | COM | 037326105 |
| NTLA | INTELLIA THERAPEUTICS INC | 25,000 | $688K | 0.2% | $27.51 | $27.78 | 0.0% | COM | 45826J105 |